骨肉瘤中的Sirtuins:破解密码并开辟新的治疗选择
Yushi Zhao1, Yong Han2, Baichuan Wang3
1Institute of Advanced Pharmaceutical Technology, Academy of Nutrition and Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, College of Medicine, Wuhan University of Science and Technology, College of Medicine.
Current pharmaceutical biotechnology
|April 28, 2025
概括
新的研究探讨了sirtuins (静音信息调节器),一种酶家族,作为治疗骨髓瘤 (OS),一种具有挑战性的骨癌的潜在目标. 了解这些蛋白质可能会导致转移性和复发性OS的改善疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 骨髓瘤 (OS) 是一种常见于青少年和老年人中的主要骨癌,其特点是转移和复发率高.
- 目前对转移性和复发性OS的治疗策略显示出有限的疗效,需要新的治疗方法.
- 赛尔图因 (静音信息调节剂) 是一种依赖NAD+的基因素脱乙酶家族,涉及到与癌症相关的各种细胞过程.
研究的目的:
- 在骨髓瘤 (OS) 发育的背景下,审查目前关于素 (SIRT1-7) 的研究.
- 阐明sirtuins在OS进展中的特定作用和机制,包括扩散,转移和化学抵抗.
- 为了确定针对sirtuins的潜在治疗应用,以改善OS治疗结果.
主要方法:
- 文献综述总结了关于Sirtuins和骨肉瘤的现有研究.
- 分析Sirtuins (SIRT1-7) 在细胞过程中已知的功能的分析,如细胞亡,自和侵入.
- 综合当前关于sirtuin参与OS的化疗耐药性的理解.
主要成果:
- 赛尔图因参与了关键的生物过程,如癌症的扩散,入侵,转移,亡,自和化疗耐药性.
- 虽然已认识到sirtuins在癌症中的重要性,但它们在骨髓瘤中的确切功能和机制需要进一步澄清.
- 有限的报告强调需要更多的研究,以了解每个sirtuin在OS病变发生中的具体作用.
结论:
- 赛尔图因代表了在骨髓瘤中新的治疗策略的一个有希望的领域.
- 对Sirtuin的功能和机制进行进一步的研究对于开发向治疗至关重要.
- 本综述旨在指导未来的研究,以寻求 osteosarcoma 治疗和研究的新途径.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K


